Literature DB >> 22774411

Effects of mesenchymal stem cells in critical size bone defect.

S Agacayak1, B Gulsun, M C Ucan, E Karaoz, Y Nergiz.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of this study was to compare culture-expanded, bone marrow-derived mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) loaded to biphasic calcium phosphate (BCP) bone ceramic in the repair of rat calvarial bone.
MATERIALS AND METHODS: Critical-size (7 mm dia.) calvarial defects were prepared in the frontal-parietal bones of 90 adult female Sprague-Dawley rats. Rats were randomly divided into 5 groups, according to defect filling, as follows: Group I (n = 21), BCP; Group II (n = 21), BCP+PRP; Group III (n = 21), BCP+MSC; Group IV (n = 21), BCP+PRP+MSC; Group V (n = 6) (control), no treatment. Animals were sacrificed at 2, 8 and 12 weeks postsurgery and bone regeneration was evaluated both histologically and immunohistochemically.
RESULTS: Statistically significant differences were observed in bone osteoblastic activity in calvarial defects among the groups (p < 0.05). PRP and MSC used in combination with BCP as a defect filling resulted in greater osteoblastic bone formation activity when compared to the use of BCP alone.
CONCLUSIONS: The combination of mesenchymal stem cells, platelet rich plasma and synthetic bone substitute was found to be more effective in inducing new bone formation (osteogenesis) than the use of platelet rich plasma combined with synthetic bone substitute and the use of synthetic bone substitute alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22774411

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  14 in total

Review 1.  The role of mesenchymal stem cells in bone repair and regeneration.

Authors:  Pavel Sponer; Tomáš Kučera; Daniel Diaz-Garcia; Stanislav Filip
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-10-08

2.  Characterization of porcine mesenchymal stromal cells and their proliferative and osteogenic potential in long-term culture.

Authors:  Corinna E Zimmermann; Lars Mackens-Kiani; Yahya Acil; Hendrik Terheyden
Journal:  J Stem Cells Regen Med       Date:  2021-12-30

Review 3.  New and emerging strategies in platelet-rich plasma application in musculoskeletal regenerative procedures: general overview on still open questions and outlook.

Authors:  Francesca Salamanna; Francesca Veronesi; Melania Maglio; Elena Della Bella; Maria Sartori; Milena Fini
Journal:  Biomed Res Int       Date:  2015-05-05       Impact factor: 3.411

Review 4.  Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy.

Authors:  Jorge Zorzopulos; Steven M Opal; Andrés Hernando-Insúa; Juan M Rodriguez; Fernanda Elías; Juan Fló; Ricardo A López; Norma A Chasseing; Victoria A Lux-Lantos; Maria F Coronel; Raul Franco; Alejandro D Montaner; David L Horn
Journal:  World J Stem Cells       Date:  2017-03-26       Impact factor: 5.326

5.  Porous Polyethylene Coated with Functionalized Hydroxyapatite Particles as a Bone Reconstruction Material.

Authors:  H Fouad; Randa AlFotawi; Othman Y Alothman; Basheer A Alshammari; Musaad Alfayez; Mohamed Hashem; Amer Mahmood
Journal:  Materials (Basel)       Date:  2018-03-29       Impact factor: 3.623

Review 6.  Natural history of mesenchymal stem cells, from vessel walls to culture vessels.

Authors:  Iain R Murray; Christopher C West; Winters R Hardy; Aaron W James; Tea Soon Park; Alan Nguyen; Tulyapruek Tawonsawatruk; Lorenza Lazzari; Chia Soo; Bruno Péault
Journal:  Cell Mol Life Sci       Date:  2013-10-25       Impact factor: 9.261

7.  Repair of segmental load-bearing bone defect by autologous mesenchymal stem cells and plasma-derived fibrin impregnated ceramic block results in early recovery of limb function.

Authors:  Min Hwei Ng; Suryasmi Duski; Kok Keong Tan; Mohd Reusmaazran Yusof; Kiat Cheong Low; Isa Mohamed Rose; Zahiah Mohamed; Aminuddin Bin Saim; Ruszymah Bt Hj Idrus
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

8.  Autologous mesenchymal stem cell (MSCs) transplantation for critical-sized bone defect following a wide excision of osteofibrous dysplasia.

Authors:  Ismail Hadisoebroto Dilogo; Achmad Fauzi Kamal; Bambang Gunawan; Rangga Valentino Rawung
Journal:  Int J Surg Case Rep       Date:  2015-11-05

Review 9.  Using mesenchymal stem cells as a therapy for bone regeneration and repairing.

Authors:  Jin Shao; Weiwei Zhang; Tieyi Yang
Journal:  Biol Res       Date:  2015-11-03       Impact factor: 5.612

10.  Clinical use of adipose-derived stem cells: European legislative issues.

Authors:  Edoardo Raposio; RosaGemma Ciliberti
Journal:  Ann Med Surg (Lond)       Date:  2017-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.